Concentrations of PCBs, PCDFs and PCDDs in the blood of Yusho patients and their toxic equivalent contribution

Yusho blood and control serum were colleced in around 1991 and analyzed for congeners of PCDDs, PCDFs and PCBs. In Yusho blood, TEQ was mainly contributed by 2,3,4,7,8-penta-CDF (77–248 ppt), 1,2,3,4,7,8-hexa-CDF (15–37 ppt) and 2,3,3′,4,4′,5-hexa-CB (16–77 ppt). Total TEQ in Yusho blood (185–441 pp...

Full description

Saved in:
Bibliographic Details
Published inChemosphere (Oxford) Vol. 37; no. 9; pp. 1773 - 1780
Main Authors Masuda, Yoshito, Schecter, Arnold, Päpke, Olaf
Format Journal Article Conference Proceeding
LanguageEnglish
Published Oxford Elsevier Ltd 01.10.1998
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Yusho blood and control serum were colleced in around 1991 and analyzed for congeners of PCDDs, PCDFs and PCBs. In Yusho blood, TEQ was mainly contributed by 2,3,4,7,8-penta-CDF (77–248 ppt), 1,2,3,4,7,8-hexa-CDF (15–37 ppt) and 2,3,3′,4,4′,5-hexa-CB (16–77 ppt). Total TEQ in Yusho blood (185–441 ppt) was only 3–14 times higher than that of control serum (31–61 ppt). It is notable that the concentrations of 3,3′,4,4′,5-, 2,3,3′,4,4′- and 2,3′,4,4′,5-penta-CBs in Yusho blood were comparable to or lower up to 3–5 times than those in control blood.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0045-6535
1879-1298
DOI:10.1016/S0045-6535(98)00242-2